Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection
Autor: | Lagging, Martin, Langeland, Nina, Pedersen, Court, Färkkilä, Martti, Buhl, Mads Rauning, Mørch, Kristine, Dhillon, Amar P, Alsiö, Asa, Hellstrand, Kristoffer, Westin, Johan, Christensen, Peer, Leutscher, Peter, Norkrans, Gunnar, Study Group, NORDynamIC |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2008 |
Předmět: |
Time Factors
Genotype Hepacivirus Hepatitis C virus Alpha interferon Interferon alpha-2 medicine.disease_cause Antiviral Agents Drug Administration Schedule Polyethylene Glycols law.invention 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Pegylated interferon law Ribavirin medicine Humans 030212 general & internal medicine Dosing Dose-Response Relationship Drug Hepatology biology Interferon Alfa-2a business.industry Body Weight Interferon-alpha Hepatitis C Chronic biology.organism_classification Virology Recombinant Proteins 3. Good health chemistry Recombinant DNA RNA Viral Drug Therapy Combination 030211 gastroenterology & hepatology business medicine.drug |
Zdroj: | Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, M R, Mørch, K, Dhillon, A P, Alsiö, A, Hellstrand, K, Westin, J, Christensen, P, Leutscher, P, Norkrans, G & Study Group, NORDC 2008, ' Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection ', Hepatology, vol. 48, no. 2, pp. 695 . https://doi.org/10.1002/hep.22450 Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, M R, Mørch, K, Dhillon, A P, Alsiö, A, Hellstrand, K, Westin, J, Christensen, P, Leutscher, P, Norkrans, G & NORDynamIC Study Group 2008, ' Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection ', Hepatology, vol. 48, no. 2, pp. 695 . https://doi.org/10.1002/hep.22450 |
DOI: | 10.1002/hep.22450 |
Popis: | Udgivelsesdato: 2008-Jul-29 |
Databáze: | OpenAIRE |
Externí odkaz: |